A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 225 participants.
Also called NCT02785120
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 225 participants
- Sponsor
- Techfields Inc
- Registry
-
NCT02785120
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Suspended
Technical summary
Registry record NCT02785120. Randomized; triple masking; primary purpose treatment. Start 2017-03-01 (actual); primary completion 2024-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes
- Acronym
- TF0023
- Condition
- Ischemic Stroke
- Intervention (Drug)
- TF0023
- Lead sponsor
- Techfields Inc
Record details
- Record id
cardio:ct-nct02785120- Content hash
8e846642ad604eea047b26630adc63a456d748ed538b3d14c4817ee0802c52f0